Gabitril Potential In Anxiety Is Aided By Favorable Side Effect Profile, Cephalon Says

The company hopes to add an indication for generalized anxiety disorder by 2006. Cephalon expects anti-epileptic Gabitril will generate $100 mil. in 2004; 70% of use is for neuropsychiatric disorders.